SE421422B - Analogiforfarande for framstellning av 6-metyl-8beta-isocyanometyl-ergolin - Google Patents

Analogiforfarande for framstellning av 6-metyl-8beta-isocyanometyl-ergolin

Info

Publication number
SE421422B
SE421422B SE7513640A SE7513640A SE421422B SE 421422 B SE421422 B SE 421422B SE 7513640 A SE7513640 A SE 7513640A SE 7513640 A SE7513640 A SE 7513640A SE 421422 B SE421422 B SE 421422B
Authority
SE
Sweden
Prior art keywords
8beta
isocyanomethyl
ergoline
methyl
preparation
Prior art date
Application number
SE7513640A
Other languages
English (en)
Swedish (sv)
Other versions
SE7513640L (sv
Inventor
E C Kornfeld
N J Bach
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of SE7513640L publication Critical patent/SE7513640L/xx
Publication of SE421422B publication Critical patent/SE421422B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/02—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with hydrocarbon or substituted hydrocarbon radicals, attached in position 8
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE7513640A 1974-12-06 1975-12-03 Analogiforfarande for framstellning av 6-metyl-8beta-isocyanometyl-ergolin SE421422B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/530,318 US3985752A (en) 1974-12-06 1974-12-06 6-Methyl-8-(substituted) methylergolines

Publications (2)

Publication Number Publication Date
SE7513640L SE7513640L (sv) 1976-06-08
SE421422B true SE421422B (sv) 1981-12-21

Family

ID=24113213

Family Applications (2)

Application Number Title Priority Date Filing Date
SE7513640A SE421422B (sv) 1974-12-06 1975-12-03 Analogiforfarande for framstellning av 6-metyl-8beta-isocyanometyl-ergolin
SE7513641A SE421423B (sv) 1974-12-06 1975-12-03 Analogiforfarande for framstellning av 6-metyl-8beta-(substituerad metyl) ergoliner

Family Applications After (1)

Application Number Title Priority Date Filing Date
SE7513641A SE421423B (sv) 1974-12-06 1975-12-03 Analogiforfarande for framstellning av 6-metyl-8beta-(substituerad metyl) ergoliner

Country Status (29)

Country Link
US (1) US3985752A (fr)
JP (2) JPS5946235B2 (fr)
AR (2) AR208104A1 (fr)
AT (2) AT348141B (fr)
AU (1) AU498226B2 (fr)
BE (1) BE836308A (fr)
BG (3) BG33287A3 (fr)
CA (2) CA1062252A (fr)
CH (2) CH617197A5 (fr)
CS (2) CS199609B2 (fr)
DD (2) DD123749A5 (fr)
DE (1) DE2554000A1 (fr)
DK (2) DK547675A (fr)
ES (3) ES443275A1 (fr)
FR (1) FR2293203A1 (fr)
GB (1) GB1526835A (fr)
GR (2) GR60026B (fr)
HU (3) HU175228B (fr)
IE (1) IE42372B1 (fr)
IL (1) IL48573A (fr)
MX (1) MX3113E (fr)
NL (1) NL7514058A (fr)
PH (1) PH12630A (fr)
PL (3) PL102195B1 (fr)
RO (2) RO64281A (fr)
SE (2) SE421422B (fr)
SU (3) SU694075A3 (fr)
YU (2) YU304875A (fr)
ZA (1) ZA757624B (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4166182A (en) * 1978-02-08 1979-08-28 Eli Lilly And Company 6-n-propyl-8-methoxymethyl or methylmercaptomethylergolines and related compounds
AU526764B2 (en) * 1978-09-08 1983-01-27 Farmitalia Carlo Erba S.P.A. Ergoline derivatives
HU180467B (en) * 1979-07-12 1983-03-28 Gyogyszerkutato Intezet Process for producing new ergol-8-ene- and ergoline-sceleted compounds
US4683313A (en) * 1985-06-24 1987-07-28 Eli Lilly And Company 2-alkyl(or phenyl)thio-6-N alkyl ergolines and 4-dialkylaminotetrahydrobenz[c,d]indoles
JPH0541005Y2 (fr) * 1987-07-14 1993-10-18
JPH02174820A (ja) * 1988-12-27 1990-07-06 Sekisui Chem Co Ltd トイレット
WO2000054776A1 (fr) * 1999-03-17 2000-09-21 Eugen Eigenmann Utilisation d'inhibiteurs de la prolactine dans le traitement des problemes de fecondite dans diverses especes animales
US20070243240A9 (en) * 2000-08-24 2007-10-18 Fred Windt-Hanke Transdermal therapeutic system

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1695752C3 (de) * 1966-07-29 1974-06-06 Societa Farmaceutici Italia, Mailand (Italien) 1 ,ö-Dimethyl-ebeta-N-carbobenzoxyaminomethyl-2,3-dihydro-1 Oalpha-ergolin und ein Verfahren zu seiner Herstellung
BE712054A (fr) * 1967-03-16 1968-07-15

Also Published As

Publication number Publication date
RO65456A (fr) 1980-01-15
AR208104A1 (es) 1976-11-30
BG33287A3 (en) 1983-01-14
IE42372B1 (en) 1980-07-30
GR60025B (en) 1978-03-31
DK547575A (fr) 1976-06-07
DE2554000A1 (de) 1976-06-16
US3985752A (en) 1976-10-12
GB1526835A (en) 1978-10-04
JPS5182300A (fr) 1976-07-19
IE42372L (en) 1976-06-06
CH617197A5 (fr) 1980-05-14
CS199609B2 (en) 1980-07-31
CA1062252A (fr) 1979-09-11
IL48573A (en) 1979-03-12
MX3113E (es) 1980-04-18
SU724085A3 (ru) 1980-03-25
GR60026B (en) 1978-03-31
USB530318I5 (fr) 1976-01-13
ATA927975A (de) 1978-04-15
ATA927875A (de) 1978-06-15
CS200483B2 (en) 1980-09-15
AU8718275A (en) 1977-06-09
JPS59210085A (ja) 1984-11-28
BE836308A (fr) 1976-06-08
PL102195B1 (pl) 1979-03-31
DD123749A5 (fr) 1977-01-12
DK142321C (fr) 1981-03-09
FR2293203A1 (fr) 1976-07-02
DK142321B (da) 1980-10-13
FR2293203B1 (fr) 1978-07-28
JPS6017795B2 (ja) 1985-05-07
JPS5946235B2 (ja) 1984-11-10
YU304875A (en) 1982-02-28
CH619465A5 (fr) 1980-09-30
IL48573A0 (en) 1976-01-30
AT348141B (de) 1979-01-25
DK547675A (da) 1976-06-07
DD123748A5 (fr) 1977-01-12
YU304775A (en) 1982-02-28
SE7513641L (sv) 1976-06-08
ES443275A1 (es) 1977-09-16
HU173847B (hu) 1979-09-28
ZA757624B (en) 1977-07-27
ES443276A1 (es) 1977-08-16
NL7514058A (nl) 1976-06-09
CA1062253A (fr) 1979-09-11
PL106884B1 (pl) 1980-01-31
AT347050B (de) 1978-12-11
HU173724B (hu) 1979-07-28
ES457709A1 (es) 1978-03-01
HU175228B (hu) 1980-06-28
SE7513640L (sv) 1976-06-08
PL102198B1 (pl) 1979-03-31
RO64281A (fr) 1979-07-15
SE421423B (sv) 1981-12-21
SU694075A3 (ru) 1979-10-25
AR207664A1 (es) 1976-10-22
BG33288A3 (en) 1983-01-14
SU685155A3 (ru) 1979-09-05
AU498226B2 (en) 1979-02-22
BG33435A3 (en) 1983-02-15
PH12630A (en) 1979-07-05

Similar Documents

Publication Publication Date Title
SE403630B (sv) Forfarande vid framstellning av flortyg
SE420095B (sv) Analogiforfarande for framstellning av 8-tiometyl-ergoliner
SE7513085L (sv) Forfarande for framstellning av etrar
TR19139A (tr) Laktatdehidrojenazenin izoenzimlerinin hepbirden tesbitine mahsus usul
NO146096C (no) Analogifremgangsmaate ved fremstilling av thienothiazinderivater
SE419548B (sv) Analogiforfarande for framstellning av 1-metyl-dihydrolysegoyl-nitroargininol-dekanoat
SE421209B (sv) Analogiforfarande for framstellning av tienobensodiazepiner
SE7506160L (sv) Forfarande for framstellning av n-cykloalkylmetyldekahydroisokinoline
SE403703B (sv) Forfarande for framstellning av s-sulfonerade immunoglobuliner
SE409452B (sv) Forfarande for framstellning av stilbenderivat
SE421921B (sv) Analogiforfarande for framstellning av pyridobensodiazepinoner
SE7506237L (sv) Forfarande for framstellning av dekahydroisokinolinderivat
NO143625C (no) Analogifremgangsmaate for fremstilling av 2-metoksy-benzamider
SE425790B (sv) Forfarande for framstellning av polylaurinlactam
SE421422B (sv) Analogiforfarande for framstellning av 6-metyl-8beta-isocyanometyl-ergolin
SE430895B (sv) Forfarande for kontinuerlig framstellning av cellulosaglykolat
SE411453B (sv) Forfarande for framstellning av 3-fluorcefalosporiner
SE403477B (sv) Forfarande for famstellning av substituerade indoleniner
SE426827B (sv) Nytt forfarande for framstellning av 7beta-acylamino-7alfa-alkoxicefalosporiner
SE7513302L (sv) Framstellning av etrar
SE7513739L (sv) Forfarande for framstellning av 2-scyl-4-oxo-pyrazino-isokonolin-derivat
SE7513879L (sv) Forfarande for syntes av karbamider
SE7511801L (sv) Forfarande for framstellning av ympsampolymerisat
SE388854B (sv) Forfarande for framstellning av fenylpyridylaminderivat
SE7506196L (sv) Forfarande for framstellning av amidin-hydrazon-derivat

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 7513640-8

Effective date: 19880923

Format of ref document f/p: F